leisure time -WSS

leisure time

author：focus 2025-10-01 17:34:05 - browse：657

Doctor Monica Bertagnolli, a white woman with short hair and bangs, sits at a hearing behind her name tag — coverage from STAT — National Institutes of Health Director Monica Bertagnolli testifies during her Senate HELP Committee confirmation hearing on Oct. 18 in Washington. Kevin Dietsch/Getty Images

WASHINGTON — The new National Institutes of Health director, Monica Bertagnolli, said it’s a “failure” that enrollment in government-funded clinical trials has lagged behind those funded by the pharmaceutical industry.

“If you just look at the number of patients who go on government-funded trials, it’s been completely flat over the last decade,” she said at a meeting of the advocacy group Friends of Cancer Research. “If you go and look at the number of people who go on pharma-sponsored trials, it’s just this commitment and this increase.”

A Johns Hopkins University study published in 2015 showed that the pharmaceutical industry funds six times more clinical trials than the government. Industry-sponsored trials increased 43% from 2006 to 2014, while newly registered NIH-funded trials decreased 24% over the same period.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Adopting new red light myopia treatments may be short

WSS

Unique patient identifier: Experts argue the benefits, pitfalls

Top private equity targets in 2023: cardiology, clinical trials, lasers

Should insurance cover cosmetic surgery?

Decentralized clinical trials need collaboration to achieve wider use

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

leisure time

leisure time

entertainment

Supreme Court strikes down use of affirmative action

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Psychedelics group wrestles with new pharma identity

Gene therapy for Afghan refugees’ infant will be fully covered

Walensky prepares to leave CDC — and Congress — behind

Should insurance cover cosmetic surgery?

Trump demands the U.S. pay no more for drugs than other countries … again

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Hepatitis C has a cure — but many Americans still lack access to it

Why CTE doesn’t keep Americans from enjoying the Super Bowl

hotspot

Lawsuit challenges CMS nursing home minimum staffing rule

Protect nursing home residents from future pandemics

Surgery pushed Ben Carson to fame

Clinicians often fail to acknowledge the pain caused by long Covid

Global cancer cases to surge 77% by 2050, WHO report says

Global cancer cases to surge 77% by 2050, WHO report says

focus

focus

knowledge

focus